Jessica M. Bibliowicz

Dr. Harrington, a cardiologist and chair of the Department of Medicine at Stanford University, will begin his new position on Sept. 12.

A Cornell University alumnus, Meyer ’49, along with his beloved wife Sandra, was a generous and committed champion of Weill Cornell Medicine, with an enduring passion for medical research and philanthropy.

Robert J. “Bob” Appel ’53, a vice chair of Weill Cornell Medicine’s Board of Fellows, Cornell trustee emeritus and presidential councillor, died Nov. 19 in New York, at age 91.

The Cornell Board of Trustees and Weill Cornell Medicine Board of Fellows approved the appointment of Dr. Lee, effective Jan. 1.

Dr. Jedd Wolchok, an internationally acclaimed medical oncologist whose innovations in immunotherapy have revolutionized melanoma treatment, has been recruited as the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, effective Sept. 12.

With more than $750 million raised already, the campaign creates a new synergy between Weill Cornell Medicine’s tri-partite mission to care, discover and teach, with a laser focus on three areas. 

Building on a legacy of groundbreaking advances in medicine and science, Weill Cornell Medicine today launched an ambitious $1.5 billion campaign—with more than $750 million already raised—that will harness emerging biomedical innovations to bring exemplary care to patients and create enduring change in medicine.

A transformative new scholarship program established by Weill Cornell Medicine will eliminate medical education debt for all students who qualify for financial aid. 

Dr. Geraldine McGinty, chief strategy officer of Weill Cornell Medicine’s Physician Organization, has been named the 2019 recipient of the Jessica M. and Natan Bibliowicz Award for Excellence in Mentoring Women Faculty. 

With a $7.5 million gift from the Friedman Family Foundation endowed by Stephen and Vice Chair Overseer Barbara Friedman, Weill Cornell Medicine has established an innovative cross-campus center dedicated to improving human health through research in the complex relationship between nutrition, inflammation and the development of disease.

For Weill Cornell Medicine, 1998 was a banner year. Amid its centennial celebration, the academic medical institution renamed itself in deep appreciation for Joan and Sanford I. Weill and their exemplary leadership, launching a bright, new era of dynamic expansion. 

Mark Veich, an accomplished leader in institutional advancement, has been appointed vice provost for external affairs at Weill Cornell Medicine, effective Feb. 12.

Dr. Augustine M.K. Choi has been appointed interim dean of Weill Cornell Medicine and interim provost for medical affairs of Cornell University, starting June 1.

After two decades of growth that has transformed Weill Cornell Medical College into a global healthcare leader, the institution reveals a new name -- Weill Cornell Medicine -- which more comprehensively captures the full scope of its mission.

After 20 years of bold and visionary leadership, Sanford I. Weill will retire as chair of the Weill Cornell Board of Overseers. Jessica M. Bibliowicz, successful business executive, named new chair of the board.